Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Listen Now

Bioanalytics
Partner Presentation

Navigating New Modalities: Tackling Biotransformation and Bioanalytical Challenges

Monday, November 10, 2025
9:30 AM - 10:30 AM CT
Location:360 Stage #4, Exhibit Hall

Sponsored By 
Bioanalytics Partner Presentation-Bioanalytics

    Partner Presentation Speaker(s)

  • Hong Zhang, PhD (he/him/his)

    Director, WuXi AppTec DMPK Department
    WuXi AppTec
    Shanghai, Shanghai, China (People's Republic)

  • Peiwen Zhang, PhD

    Principal Investigator/Study Director, Clinical Bioanalysis
    WuXi AppTec
    Shanghai, Shanghai, China (People's Republic)

This session explores the biotransformation and bioanalysis challenges associated with emerging modalities such as peptides, oligonucleotides, and ADCs. It will present strategies for investigating biotransformation in preclinical studies and ensuring robust bioanalysis during clinical development, with emphasis on regulatory considerations and practical solutions for therapeutic products. Attendees will gain actionable insights to help accelerate new therapies from discovery through regulatory submission.

Learning Objectives:

  • Understand biotransformation and bioanalytical challenges in new modalities
  • Gain insights into strategies and solutions from our expertise and practice
  • Understand key regulatory considerations for drug development